EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H18O7 |
| Net Charge | 0 |
| Average Mass | 382.368 |
| Monoisotopic Mass | 382.10525 |
| SMILES | [H]C(=O)c1c(O)cc(C)c2c1Oc1cc(O)c(C(=O)C=C(C)C)c(C)c1OC2=O |
| InChI | InChI=1S/C21H18O7/c1-9(2)5-14(24)18-11(4)19-16(7-15(18)25)27-20-12(8-22)13(23)6-10(3)17(20)21(26)28-19/h5-8,23,25H,1-4H3 |
| InChIKey | GRJLKDCRKHDXSZ-UHFFFAOYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Chaetomium brasiliense (ncbitaxon:155871) | - | PubMed (19663417) |
| Roles Classification |
|---|
| Biological Roles: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antimycobacterial drug A drug used to treat or prevent infections caused by Mycobacteria, a genus of actinobacteria. Aerobic and nonmotile, members of the genus include the pathogens responsible for causing tuberculosis and leprosy. Chaetomium metabolite Any fungal metabolite produced during a metabolic reaction in the mould, Chaetomium. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antimycobacterial drug A drug used to treat or prevent infections caused by Mycobacteria, a genus of actinobacteria. Aerobic and nonmotile, members of the genus include the pathogens responsible for causing tuberculosis and leprosy. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| mollicellin K (CHEBI:68724) has role Chaetomium metabolite (CHEBI:76960) |
| mollicellin K (CHEBI:68724) has role antimalarial (CHEBI:38068) |
| mollicellin K (CHEBI:68724) has role antimycobacterial drug (CHEBI:64912) |
| mollicellin K (CHEBI:68724) has role antineoplastic agent (CHEBI:35610) |
| mollicellin K (CHEBI:68724) is a aldehyde (CHEBI:17478) |
| mollicellin K (CHEBI:68724) is a aromatic ketone (CHEBI:76224) |
| mollicellin K (CHEBI:68724) is a depsidones (CHEBI:75939) |
| mollicellin K (CHEBI:68724) is a enone (CHEBI:51689) |
| mollicellin K (CHEBI:68724) is a organic heterotricyclic compound (CHEBI:26979) |
| mollicellin K (CHEBI:68724) is a polyphenol (CHEBI:26195) |
| IUPAC Name |
|---|
| 3,7-dihydroxy-1,9-dimethyl-8-(3-methylbut-2-enoyl)-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-4-carbaldehyde |
| Manual Xrefs | Databases |
|---|---|
| 24676109 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| Reaxys:19895966 | Reaxys |
| Citations |
|---|